FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1512720088> ?p ?o ?g. }

• W1512720088 endingPage "200" @default.
• W1512720088 startingPage "169" @default.
• W1512720088 abstract "The acquisition of resistance to conventional therapies such as radiation and chemotherapeutic drugs remains the major obstacle in the successful treatment of cancer patients. Tumor cells acquire resistance to apoptotic stimuli and it has been demonstrated that conventional therapies exert their cytotoxic activities primarily by inducing apoptosis in the cells. Resistance to radiation and chemotherapeutic drugs has led to the development of immunotherapy and gene therapy approaches with the intent of overcoming resistance to drugs and radiation as well as enhancing the specificity to eliminate tumor cells. However, cytotoxic lymphocytes primarily kill by apoptosis and, therefore, drug-resistant tumor cells may also be cross-resistant to immunotherapy. To evade apoptosis, tumor cells have adopted various mechanisms that interfere with the apoptotic signaling pathways and promote constitutive activation of cellular proliferation and survival pathways. Thus, modifications of the antiapoptotic genes in cancer cells are warranted for the effectiveness of conventional therapies as well as novel immunotherapeutic approaches. Such modifications will avert the resistant phenotype of the tumor cells and will render them susceptible to apoptosis. Current studies, both in vitro and preclinically in vivo, have been aimed at the modification and regulation of expression of apoptosis-related gene products and their activities. A novel protein designated Raf-1 kinase inhibitor protein (RKIP) has been partially characterized. RKIP is a member of the phosphatidylethanolamine-binding protein family. RKIP has been shown to disrupt the Raf-1-MEK1/2 [mitogen-activated protein kinase-ERK (extracellular signal-regulated kinase) kinase-1/2]-ERK1/2 and NF-kappaB signaling pathways, via physical interaction with Raf-1-MEK1/2 and NF-kappaB-inducing kinase or transforming growth factor beta-activated kinase-1, respectively, thereby abrogating the survival and antiapoptotic properties of these signaling pathways. In addition, RKIP has been shown to act as a signal modifier that enhances receptor signaling by inhibiting G protein-coupled receptor kinase-2. By regulating cell signaling, growth, and survival through its expression and activity, RKIP is considered to play a pivotal role in cancer, regulating apoptosis induced by drugs or immune-mediated stimuli. Overexpression of RKIP sensitizes tumor cells to chemotherapeutic drug-induced apoptosis. Also, induction of RKIP by drugs or anti-receptor antibodies sensitizes cancer cells to drug-induced apoptosis. In this review, we discuss the discovery, structure, function, and significance of RKIP in cancer." @default.
• W1512720088 created "2016-06-24" @default.
• W1512720088 creator A5006079178 @default.
• W1512720088 creator A5010565662 @default.
• W1512720088 creator A5015648467 @default.
• W1512720088 creator A5046883603 @default.
• W1512720088 creator A5055490703 @default.
• W1512720088 creator A5083833162 @default.
• W1512720088 date "2004-01-01" @default.
• W1512720088 modified "2023-09-23" @default.
• W1512720088 title "Raf-1 Kinase Inhibitor Protein: Structure, Function, Regulation of Cell Signaling, and Pivotal Role in Apoptosis" @default.
• W1512720088 cites W1489062930 @default.
• W1512720088 cites W172691372 @default.
• W1512720088 cites W1767847062 @default.
• W1512720088 cites W1775131150 @default.
• W1512720088 cites W1862442455 @default.
• W1512720088 cites W1938103646 @default.
• W1512720088 cites W1967591282 @default.
• W1512720088 cites W1969330410 @default.
• W1512720088 cites W1973109581 @default.
• W1512720088 cites W1975403276 @default.
• W1512720088 cites W1978062354 @default.
• W1512720088 cites W1982849286 @default.
• W1512720088 cites W1982979469 @default.
• W1512720088 cites W1991865867 @default.
• W1512720088 cites W1994219871 @default.
• W1512720088 cites W1998130451 @default.
• W1512720088 cites W1998400602 @default.
• W1512720088 cites W2005423627 @default.
• W1512720088 cites W2007456673 @default.
• W1512720088 cites W2018918471 @default.
• W1512720088 cites W2025128734 @default.
• W1512720088 cites W2031272027 @default.
• W1512720088 cites W2032423298 @default.
• W1512720088 cites W2032753758 @default.
• W1512720088 cites W2034767282 @default.
• W1512720088 cites W2035860876 @default.
• W1512720088 cites W2045518029 @default.
• W1512720088 cites W2048923264 @default.
• W1512720088 cites W2053283592 @default.
• W1512720088 cites W2055825597 @default.
• W1512720088 cites W2056970736 @default.
• W1512720088 cites W2057872295 @default.
• W1512720088 cites W2061497413 @default.
• W1512720088 cites W2063208932 @default.
• W1512720088 cites W2067524077 @default.
• W1512720088 cites W2069669881 @default.
• W1512720088 cites W2070023258 @default.
• W1512720088 cites W2078324381 @default.
• W1512720088 cites W2080501134 @default.
• W1512720088 cites W2083580835 @default.
• W1512720088 cites W2089185822 @default.
• W1512720088 cites W2095578202 @default.
• W1512720088 cites W2099999460 @default.
• W1512720088 cites W2103390588 @default.
• W1512720088 cites W2106877484 @default.
• W1512720088 cites W2119093680 @default.
• W1512720088 cites W2122794637 @default.
• W1512720088 cites W2124845167 @default.
• W1512720088 cites W2125468282 @default.
• W1512720088 cites W2129041705 @default.
• W1512720088 cites W2129771300 @default.
• W1512720088 cites W2131605616 @default.
• W1512720088 cites W2136627244 @default.
• W1512720088 cites W2142242441 @default.
• W1512720088 cites W2153372363 @default.
• W1512720088 cites W2158969445 @default.
• W1512720088 cites W2164363164 @default.
• W1512720088 cites W2171569176 @default.
• W1512720088 cites W2175699771 @default.
• W1512720088 cites W4233947395 @default.
• W1512720088 cites W4241627544 @default.
• W1512720088 cites W4246984732 @default.
• W1512720088 cites W60759546 @default.
• W1512720088 doi "https://doi.org/10.1016/s0065-230x(04)91005-6" @default.
• W1512720088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15327891" @default.
• W1512720088 hasPublicationYear "2004" @default.
• W1512720088 type Work @default.
• W1512720088 sameAs 1512720088 @default.
• W1512720088 citedByCount "168" @default.
• W1512720088 countsByYear W15127200882012 @default.
• W1512720088 countsByYear W15127200882013 @default.
• W1512720088 countsByYear W15127200882014 @default.
• W1512720088 countsByYear W15127200882015 @default.
• W1512720088 countsByYear W15127200882016 @default.
• W1512720088 countsByYear W15127200882017 @default.
• W1512720088 countsByYear W15127200882018 @default.
• W1512720088 countsByYear W15127200882019 @default.
• W1512720088 countsByYear W15127200882020 @default.
• W1512720088 countsByYear W15127200882021 @default.
• W1512720088 countsByYear W15127200882022 @default.
• W1512720088 countsByYear W15127200882023 @default.
• W1512720088 crossrefType "book-chapter" @default.
• W1512720088 hasAuthorship W1512720088A5006079178 @default.
• W1512720088 hasAuthorship W1512720088A5010565662 @default.
• W1512720088 hasAuthorship W1512720088A5015648467 @default.
• W1512720088 hasAuthorship W1512720088A5046883603 @default.
• W1512720088 hasAuthorship W1512720088A5055490703 @default.

• next